E-ISSN 2149-388X | ISSN 2149-0430
 

Original Article 


Depression as a Prodromal Marker and Dementia as a Terminal Symptom in Parkinson’s Disease

Aydın Cagac, Bilal Bayram.

Abstract
Introduction: In our study, we aimed to examine the relationship between depression and dementia, which are the most common prodromal and terminal symptoms in Parkinson’s disease.
Materials and Methods: Patients with Parkinson’s disease who presented to the Neurology outpatient clinic were evaluated on selected from October 2020 and February 2021. A total of 87 patients with Hoehn and Yahr stage 1-4 were included in the study. Of the Parkinson’s patients, 37 were female and 50 were male. Hamilton Depression Rating Scale for depression and Mini-Mental Test score was used for dementia.
Results: The duration of the disease did not make a significant difference between the sexes in depression and dementia. In contrast to dementia in the descriptive statistics according to the H-Y stage, depression is observed at all stages of Hoehn and Yahr. In Parkinson’s disease, dementia is more common in advanced-stage patients, which is associated with the course of the disease. According to the HAM-D scale, the mean depression values were 21 in male patients and 19 in female patients. Mean dementia in men and women was 22 according to the MMSE scale.
Conclusion: Depression and dementia are important determinants of the poor health-related quality of life in Parkinson’s disease. Patients should be provided with the best treatment via a multidisciplinary team.

Key words: Parkinson disease, depression, dementia


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Aydın Cagac
Articles by Bilal Bayram
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Aydın Cagac| Bilal Bayram. Depression as a Prodromal Marker and Dementia as a Terminal Symptom in Parkinson’s Disease. Ulutas Med J. 2021; 7(3): 165-171. doi:10.5455/umj.20210825045313


Web Style

Aydın Cagac| Bilal Bayram. Depression as a Prodromal Marker and Dementia as a Terminal Symptom in Parkinson’s Disease. http://www.ulutasmedicaljournal.com/?mno=115102 [Access: September 24, 2021]. doi:10.5455/umj.20210825045313


AMA (American Medical Association) Style

Aydın Cagac| Bilal Bayram. Depression as a Prodromal Marker and Dementia as a Terminal Symptom in Parkinson’s Disease. Ulutas Med J. 2021; 7(3): 165-171. doi:10.5455/umj.20210825045313



Vancouver/ICMJE Style

Aydın Cagac| Bilal Bayram. Depression as a Prodromal Marker and Dementia as a Terminal Symptom in Parkinson’s Disease. Ulutas Med J. (2021), [cited September 24, 2021]; 7(3): 165-171. doi:10.5455/umj.20210825045313



Harvard Style

Aydın Cagac| Bilal Bayram (2021) Depression as a Prodromal Marker and Dementia as a Terminal Symptom in Parkinson’s Disease. Ulutas Med J, 7 (3), 165-171. doi:10.5455/umj.20210825045313



Turabian Style

Aydın Cagac| Bilal Bayram. 2021. Depression as a Prodromal Marker and Dementia as a Terminal Symptom in Parkinson’s Disease. THE ULUTAS MEDICAL JOURNAL, 7 (3), 165-171. doi:10.5455/umj.20210825045313



Chicago Style

Aydın Cagac| Bilal Bayram. "Depression as a Prodromal Marker and Dementia as a Terminal Symptom in Parkinson’s Disease." THE ULUTAS MEDICAL JOURNAL 7 (2021), 165-171. doi:10.5455/umj.20210825045313



MLA (The Modern Language Association) Style

Aydın Cagac| Bilal Bayram. "Depression as a Prodromal Marker and Dementia as a Terminal Symptom in Parkinson’s Disease." THE ULUTAS MEDICAL JOURNAL 7.3 (2021), 165-171. Print. doi:10.5455/umj.20210825045313



APA (American Psychological Association) Style

Aydın Cagac| Bilal Bayram (2021) Depression as a Prodromal Marker and Dementia as a Terminal Symptom in Parkinson’s Disease. THE ULUTAS MEDICAL JOURNAL, 7 (3), 165-171. doi:10.5455/umj.20210825045313